Eykyn S, Jenkins C, King A, Phillips I
Antimicrob Agents Chemother. 1976 Apr;9(4):690-5. doi: 10.1128/AAC.9.4.690.
The in vitro activity of cefuroxime, a new cephalosporin derivative, was compared with that of cephaloridine, cephalothin, and cefamandole against strains of gram-positive and gram-negative bacteria recently isolated from clinical sources. Cefuroxime showed very similar activity to cefamandole against Staphylococcus aureus, Haemophilus influenzae, and most members of the Enterobacteriaceae. It was more active than cefamandole against gonococci, pneumococci, and most streptococci. Increasing the inoculum size appeared to have less effect on the minimum inhibitory concentrations of cefuroxime for gram-negative bacilli than has been found with the other cephalosporin derivatives, and minimum bactericidal concentrations of cefuroxime were only marginally greater than minimum inhibitory concentrations.
将一种新型头孢菌素衍生物头孢呋辛的体外活性与头孢噻啶、头孢噻吩和头孢孟多针对近期从临床分离出的革兰氏阳性菌和革兰氏阴性菌菌株的活性进行了比较。头孢呋辛对金黄色葡萄球菌、流感嗜血杆菌和大多数肠杆菌科成员显示出与头孢孟多非常相似的活性。它对淋球菌、肺炎球菌和大多数链球菌的活性比头孢孟多更强。与其他头孢菌素衍生物相比,增加接种量对头孢呋辛对革兰氏阴性杆菌的最低抑菌浓度影响似乎较小,且头孢呋辛的最低杀菌浓度仅略高于最低抑菌浓度。